Docosahexaenoic Acid (DHA) Market Outlook:
Docosahexaenoic Acid (DHA) Market size was valued at USD 5.25 billion in 2025 and is expected to reach USD 13.49 billion by 2035, expanding at around 9.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of docosahexaenoic acid is assessed at USD 5.72 billion.
The reason behind the growth is impelled by escalating cases of depression. One such factor that sets off depression in a person is a deficiency in docosahexaenoic acid (DHA), as taking EPA and DHA Omega-3s is associated with a significant reduction in depressive symptoms. Thus, the surge in cases of depression throughout the world is anticipated to drive market growth in the coming years. As reported in the World Health Organization (WHO) 2021 report, depression affected an estimated 5% of individuals globally.
The surging risk of preterm births across the globe is believed to fuel DHA market growth. The risk of death or major disability increases with the preterm birth of a baby. For instance, by the end of 2020, over 16 million preterm births occurred globally, resulting in an 11% preterm birth rate worldwide. Along with this, premature birth is the main cause of mortality in children, responsible for up to 37% of infant deaths and nearly 19% of all deaths in children under the age of 5 years.
DHA helps in reducing the risk of preterm birth by providing essential nutrients to the fetus. Hence, the surging risk of preterm births is also estimated to spur market growth in the coming years.
